267 related articles for article (PubMed ID: 18042441)
1. A single centre experience of liver disease in adults with cystic fibrosis 1995-2006.
Nash KL; Allison ME; McKeon D; Lomas DJ; Haworth CS; Bilton D; Alexander GJ
J Cyst Fibros; 2008 May; 7(3):252-7. PubMed ID: 18042441
[TBL] [Abstract][Full Text] [Related]
2. The benign course of liver disease in adults with cystic fibrosis and the effect of ursodeoxycholic acid.
Desmond CP; Wilson J; Bailey M; Clark D; Roberts SK
Liver Int; 2007 Dec; 27(10):1402-8. PubMed ID: 18036103
[TBL] [Abstract][Full Text] [Related]
3. Cystic fibrosis-associated liver disease.
Herrmann U; Dockter G; Lammert F
Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):585-92. PubMed ID: 20955961
[TBL] [Abstract][Full Text] [Related]
4. Portal hypertension and primary biliary cirrhosis: effect of long-term ursodeoxycholic acid treatment.
Huet PM; Vincent C; Deslaurier J; Coté J; Matsutami S; Boileau R; Huet-van Kerckvoorde J
Gastroenterology; 2008 Nov; 135(5):1552-60. PubMed ID: 18722374
[TBL] [Abstract][Full Text] [Related]
5. Ursodeoxycholic acid treatment in patients with cystic fibrosis at risk for liver disease.
Siano M; De Gregorio F; Boggia B; Sepe A; Ferri P; Buonpensiero P; Di Pasqua A; Raia V
Dig Liver Dis; 2010 Jun; 42(6):428-31. PubMed ID: 20034860
[TBL] [Abstract][Full Text] [Related]
6. A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease.
Lindblad A; Glaumann H; Strandvik B
Hepatology; 1998 Jan; 27(1):166-74. PubMed ID: 9425933
[TBL] [Abstract][Full Text] [Related]
7. Liver disease in cystic fibrosis.
Colombo C; Apostolo MG; Assaisso M; Roman B; Bottani P
Neth J Med; 1992 Oct; 41(3-4):119-22. PubMed ID: 1470280
[TBL] [Abstract][Full Text] [Related]
8. Partial splenectomy for portal hypertension in cystic fibrosis related liver disease.
Louis D; Duc ML; Reix P; Chazalette JP; Durieu I; Feigelson J; Bellon G
Pediatr Pulmonol; 2007 Dec; 42(12):1173-80. PubMed ID: 17968998
[TBL] [Abstract][Full Text] [Related]
9. Ursodeoxycholic acid treatment in isolated chronic graft-vs.-host disease of the liver.
Arat M; Idilman R; Soydan EA; Soykan I; Erden E; Karayalçin S; Akan H
Clin Transplant; 2005 Dec; 19(6):798-803. PubMed ID: 16313328
[TBL] [Abstract][Full Text] [Related]
10. Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy.
Färkkilä M; Rautiainen H; Kärkkäinen P; Karvonen AL; Nurmi H; Niemelä O
Liver Int; 2008 Jul; 28(6):787-97. PubMed ID: 18397236
[TBL] [Abstract][Full Text] [Related]
11. Features of Severe Liver Disease With Portal Hypertension in Patients With Cystic Fibrosis.
Stonebraker JR; Ooi CY; Pace RG; Corvol H; Knowles MR; Durie PR; Ling SC
Clin Gastroenterol Hepatol; 2016 Aug; 14(8):1207-1215.e3. PubMed ID: 27062904
[TBL] [Abstract][Full Text] [Related]
12. [Pulmonary function after liver transplantation in cystic fibrosis. Report of four cases].
Urgellés Fajardo E; Barrio Gómez de Agüero MI; Martínez Carrasco MC; Jara Vega P; Antelo Landeira C
An Esp Pediatr; 2001 Mar; 54(3):228-32. PubMed ID: 11262249
[TBL] [Abstract][Full Text] [Related]
13. Hepatic Manifestations of Cystic Fibrosis.
Sakiani S; Kleiner DE; Heller T; Koh C
Clin Liver Dis; 2019 May; 23(2):263-277. PubMed ID: 30947876
[TBL] [Abstract][Full Text] [Related]
14. Successful lung transplantation in spite of cystic fibrosis-associated liver disease: a case series.
Klima LD; Kowdley KV; Lewis SL; Wood DE; Aitken ML
J Heart Lung Transplant; 1997 Sep; 16(9):934-8. PubMed ID: 9322144
[TBL] [Abstract][Full Text] [Related]
15. Transient elastography to assess hepatic fibrosis in primary biliary cirrhosis.
Gómez-Dominguez E; Mendoza J; García-Buey L; Trapero M; Gisbert JP; Jones EA; Moreno-Otero R
Aliment Pharmacol Ther; 2008 Mar; 27(5):441-7. PubMed ID: 18081731
[TBL] [Abstract][Full Text] [Related]
16. Clinical and laboratory predictors of esophageal varices in children and adolescents with portal hypertension syndrome.
Fagundes ED; Ferreira AR; Roquete ML; Penna FJ; Goulart EM; Figueiredo Filho PP; Bittencourt PF; Carvalho SD; Albuquerque W
J Pediatr Gastroenterol Nutr; 2008 Feb; 46(2):178-83. PubMed ID: 18223377
[TBL] [Abstract][Full Text] [Related]
17. Liver disease in children with cystic fibrosis.
Diwakar V; Pearson L; Beath S
Paediatr Respir Rev; 2001 Dec; 2(4):340-9. PubMed ID: 12052306
[TBL] [Abstract][Full Text] [Related]
18. [Cystic fibrosis associated with liver disease].
Debray D
Arch Pediatr; 2012 May; 19 Suppl 1():S23-6. PubMed ID: 22682485
[TBL] [Abstract][Full Text] [Related]
19. Liver disease in cystic fibrosis: A prospective study on incidence, risk factors, and outcome.
Colombo C; Battezzati PM; Crosignani A; Morabito A; Costantini D; Padoan R; Giunta A
Hepatology; 2002 Dec; 36(6):1374-82. PubMed ID: 12447862
[TBL] [Abstract][Full Text] [Related]
20. Application of ursodeoxycholic acid (UDCA) in the therapy of liver and biliary duct diseases in children.
Lebensztejn DM
Med Sci Monit; 2000; 6(3):632-6. PubMed ID: 11208384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
